CHILDREN'S ALLEGRA ORAL SUSPENSION OTC
Generic Name and Formulations:
Fexofenadine HCl 30mg/5mL; contains sodium 18mg/5mL; raspberry flavor.
Indications for CHILDREN'S ALLEGRA ORAL SUSPENSION:
Allergic rhinitis (seasonal). Chronic idiopathic urticaria.
10mL every 12 hours; max 20mL/24hrs.
<2yrs: not recommended. ≥2yrs: 5mL every 12 hours; max 10mL/24hrs.
Pregnancy (Cat.C). Nursing mothers.
Avoid concomitant aluminum- or magnesium-containing antacids.
Adults: Headache, back pain, viral infection, GI upset, sinusitis, dizziness, drowsiness. Children: cough, fever, pain, otitis media, upper respiratory tract infection.
Tabs—6; ODT—6; Susp—4oz
Clinical Pain Advisor Articles
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis